Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $329.90 | 4 | 64.0% |
| Education | $185.46 | 2 | 36.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $311.07 | 3 | $0 (2022) |
| Janssen Biotech, Inc. | $118.82 | 2 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $85.47 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85.47 | 1 | Regeneron Healthcare Solutions, Inc. ($85.47) |
| 2022 | $86.02 | 1 | ABBVIE INC. ($86.02) |
| 2020 | $18.83 | 1 | Janssen Biotech, Inc. ($18.83) |
| 2018 | $225.05 | 2 | AbbVie, Inc. ($225.05) |
| 2017 | $99.99 | 1 | Janssen Biotech, Inc. ($99.99) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $85.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/20/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $86.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
| 09/21/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $108.56 | General |
| Category: Immunology | ||||||
| 04/27/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $116.49 | General |
| Category: Immunology | ||||||
| 12/14/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,305 | 5,120 | $462,457 | $173,097 |
| 2022 | 15 | 2,575 | 5,539 | $500,298 | $181,322 |
| 2021 | 18 | 1,714 | 3,061 | $338,712 | $142,781 |
| 2020 | 7 | 406 | 655 | $60,339 | $21,897 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 433 | 493 | $50,779 | $27,721 | 54.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 312 | 364 | $66,612 | $26,042 | 39.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 494 | 668 | $89,512 | $24,021 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 255 | $40,290 | $20,319 | 50.4% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 12 | 191 | $28,650 | $16,643 | 58.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 158 | 158 | $28,914 | $11,461 | 39.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 384 | 2,603 | $54,663 | $11,451 | 20.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 137 | 160 | $40,000 | $10,398 | 26.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 55 | 75 | $27,300 | $8,408 | 30.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 11 | 20 | $9,000 | $5,948 | 66.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $11,481 | $4,501 | 39.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 23 | $6,716 | $2,867 | 42.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 17 | 19 | $4,693 | $1,527 | 32.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 35 | $2,625 | $1,339 | 51.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,222 | $451.86 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 488 | 558 | $57,474 | $31,449 | 54.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 524 | 721 | $96,614 | $26,625 | 27.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 305 | 352 | $64,416 | $25,662 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 280 | $44,240 | $21,425 | 48.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 237 | 237 | $43,371 | $15,135 | 34.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 75 | 114 | $41,496 | $13,214 | 31.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 429 | 2,906 | $61,026 | $12,864 | 21.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 148 | 175 | $43,750 | $11,619 | 26.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 13 | 24 | $10,800 | $7,105 | 65.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $15,219 | $6,038 | 39.7% |
About Dr. Skyler Maher, MD
Dr. Skyler Maher, MD is a Dermatology healthcare provider based in Denton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2016. The National Provider Identifier (NPI) number assigned to this provider is 1336593524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Skyler Maher, MD has received a total of $515.36 in payments from pharmaceutical and medical device companies, with $85.47 received in 2024. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($329.90).
As a Medicare-enrolled provider, Maher has provided services to 7,000 Medicare beneficiaries, totaling 14,375 services with total Medicare billing of $519,098. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Internal Medicine, Dermatology
- Location Denton, TX
- Active Since 04/14/2016
- Last Updated 05/24/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1336593524
Products in Payments
- Humira (Biological) $225.05
- STELARA (Biological) $99.99
- RINVOQ (Biological) $86.02
- DUPIXENT (Biological) $85.47
- TREMFYA (Drug) $18.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Denton
Jason Bentow, Md, MD
Dermatology — Payments: $11,591
Cynthia Harrington, Md, MD
Dermatology — Payments: $2,263
Dr. Robert Smith, Md, MD
Dermatology — Payments: $2,191
Dr. Erin Roberts, Md, MD
Dermatology — Payments: $1,550
Dr. Meenakshi Manivannan, Md, MD
Dermatology — Payments: $922.85
Clara Henry, M.d, M.D
Dermatology — Payments: $241.73